Skip to main content

Postmenopausal Symptoms News (Page 6)

Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle

Miami, FL and New York, NY, – September 24, 2014 – Noven Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication with a new dose of...

FDA Approves Brisdelle - First Non-Hormonal Treatment for Hot Flashes Associated with Menopause

June 28, 2013 --The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which...

FDA Approves Osphena for Postmenopausal Women Experiencing Dyspareunia

February 26, 2013 – The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom...

FDA Medwatch Alert: Compounded Menopause Hormone Therapy Drugs

[Posted 01/10/2008] FDA informed healthcare professionals and patients that the Agency sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Atrophic Vaginitis, Menopausal Disorders

Related drug support groups

gabapentin, Paxil, paroxetine, estradiol, Premarin, Estrace, desvenlafaxine